BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 32033443)

  • 1. The IGF-II-Insulin Receptor Isoform-A Autocrine Signal in Cancer:
    Scalia P; Giordano A; Williams SJ
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32033443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel EphB4 phosphodegron regulated by the autocrine IGFII/IR
    Scalia P; Pandini G; Carnevale V; Giordano A; Williams SJ
    Oncogene; 2019 Aug; 38(31):5987-6001. PubMed ID: 31270394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Isoform DTX3c Associates with UBE2N-UBA1 and Cdc48/p97 as Part of the EphB4 Degradation Complex Regulated by the Autocrine IGF-II/IR
    Scalia P; Merali C; Barrero C; Suma A; Carnevale V; Merali S; Williams SJ
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.
    Avnet S; Sciacca L; Salerno M; Gancitano G; Cassarino MF; Longhi A; Zakikhani M; Carboni JM; Gottardis M; Giunti A; Pollak M; Vigneri R; Baldini N
    Cancer Res; 2009 Mar; 69(6):2443-52. PubMed ID: 19258511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine IGF-II-Associated Cancers: From a Rare Paraneoplastic Event to a Hallmark in Malignancy.
    Scalia P; Marino IR; Asero S; Pandini G; Grimberg A; El-Deiry WS; Williams SJ
    Biomedicines; 2023 Dec; 12(1):. PubMed ID: 38255147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoform- and Paralog-Switching in IR-Signaling: When Diabetes Opens the Gates to Cancer.
    Scalia P; Giordano A; Martini C; Williams SJ
    Biomolecules; 2020 Nov; 10(12):. PubMed ID: 33266015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human neuroblastoma cells use either insulin-like growth factor-I or insulin-like growth factor-II in an autocrine pathway via the IGF-I receptor: variability of IGF, IGF binding protein (IGFBP) and IGF receptor gene expression and IGF and IGFBP secretion in human neuroblastoma cells in relation to cellular proliferation.
    Kiess W; Koepf G; Christiansen H; Blum WF
    Regul Pept; 1997 Sep; 72(1):19-29. PubMed ID: 9404729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of insulin receptor A isoform and IRA/IGF-IR hybrid receptors in the aortic vascular smooth muscle cell proliferation: role of TNF-α and IGF-II.
    Gómez-Hernández A; Escribano Ó; Perdomo L; Otero YF; García-Gómez G; Fernández S; Beneit N; Benito M
    Endocrinology; 2013 Jul; 154(7):2352-64. PubMed ID: 23677929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A.
    Sciacca L; Mineo R; Pandini G; Murabito A; Vigneri R; Belfiore A
    Oncogene; 2002 Nov; 21(54):8240-50. PubMed ID: 12447687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer.
    Vella V; Pandini G; Sciacca L; Mineo R; Vigneri R; Pezzino V; Belfiore A
    J Clin Endocrinol Metab; 2002 Jan; 87(1):245-54. PubMed ID: 11788654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer.
    Stoeltzing O; Liu W; Reinmuth N; Fan F; Parikh AA; Bucana CD; Evans DB; Semenza GL; Ellis LM
    Am J Pathol; 2003 Sep; 163(3):1001-11. PubMed ID: 12937141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR.
    Denley A; Bonython ER; Booker GW; Cosgrove LJ; Forbes BE; Ward CW; Wallace JC
    Mol Endocrinol; 2004 Oct; 18(10):2502-12. PubMed ID: 15205474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells.
    Ellis MJ; Leav BA; Yang Z; Rasmussen A; Pearce A; Zweibel JA; Lippman ME; Cullen KJ
    Mol Endocrinol; 1996 Mar; 10(3):286-97. PubMed ID: 8833657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism.
    Sciacca L; Costantino A; Pandini G; Mineo R; Frasca F; Scalia P; Sbraccia P; Goldfine ID; Vigneri R; Belfiore A
    Oncogene; 1999 Apr; 18(15):2471-9. PubMed ID: 10229198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis.
    Nussbaum T; Samarin J; Ehemann V; Bissinger M; Ryschich E; Khamidjanov A; Yu X; Gretz N; Schirmacher P; Breuhahn K
    Hepatology; 2008 Jul; 48(1):146-56. PubMed ID: 18537183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop.
    Vella V; Nicolosi ML; Cantafio P; Massimino M; Lappano R; Vigneri P; Ciuni R; Gangemi P; Morrione A; Malaguarnera R; Belfiore A
    Endocr Relat Cancer; 2019 Jan; 26(1):197-214. PubMed ID: 30121624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Big'-insulin-like growth factor-II signaling is an autocrine survival pathway in gastrointestinal stromal tumors.
    Rikhof B; van der Graaf WT; Suurmeijer AJ; van Doorn J; Meersma GJ; Groenen PJ; Schuuring EM; Meijer C; de Jong S
    Am J Pathol; 2012 Jul; 181(1):303-12. PubMed ID: 22658485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Id1-induced IGF-II and its autocrine/endocrine promotion of esophageal cancer progression and chemoresistance--implications for IGF-II and IGF-IR-targeted therapy.
    Li B; Tsao SW; Chan KW; Ludwig DL; Novosyadlyy R; Li YY; He QY; Cheung AL
    Clin Cancer Res; 2014 May; 20(10):2651-62. PubMed ID: 24599933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of the insulin receptor isoform A favors formation of type 1 insulin-like growth factor receptor (IGF-IR) homodimers and enhances ligand-induced IGF-IR activation and viability of human colon carcinoma cells.
    Brierley GV; Macaulay SL; Forbes BE; Wallace JC; Cosgrove LJ; Macaulay VM
    Endocrinology; 2010 Apr; 151(4):1418-27. PubMed ID: 20179263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis.
    Beneit N; Fernández-García CE; Martín-Ventura JL; Perdomo L; Escribano Ó; Michel JB; García-Gómez G; Fernández S; Díaz-Castroverde S; Egido J; Gómez-Hernández A; Benito M
    Cardiovasc Diabetol; 2016 Dec; 15(1):161. PubMed ID: 27905925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.